This Market Action Is Once Again Sluggish

The bulls have not been able to build on strong action -- and the bears have been even more inept.
Stocks quotes in this article: QQQ, LITE, LABD, PIXY, IWM, AAOI

The bulls are working to build on yesterday's Yellen-fueled strength but, as I discussed, the pattern recently has been 'one and done.' The bulls have not been able to build on strong action and the bears have been even more inept in the other direction.

The Nasdaq 100 ETF (QQQ) started off strong but there is some weakness now. Breadth is negative, at around 2,900 to 3,250. There are nearly 200 stocks making new 12-month highs as there are some better pockets of momentum. A good example is Applied Optoelectronics (AAOI) , which is driving the optical sector after preannouncing better-than-expected second-quarter numbers. I added to my Stock of the Week in the sector -- Lumentum (LITE) .

The small-caps (IWM) are underperforming again and biotechnology is lagging. FAANG names are mixed and overall momentum is cooling quickly.

I have a biotechnology index short in the form of Direxion Biotech Bear 3X ETF  (LABD) , but as I'm leaving on vacation soon, I'm not trading very aggressively. ShiftPixy (PIXY) , which I mentioned recently, is perking up again on good volume.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long LITE, LABD and PIXY, although positions may change at any time.

TAGS: Investing | U.S. Equity | Healthcare | Technology | Markets | Stocks

More from Healthcare

3 Safe Dividends Even If the Market Crashes

Bob Ciura

Walgreens Boots Alliance, Clorox and Coca-Cola have produced reliable income streams through the best and worst of times.

More Big Deals for Health Care Eyed in 2022

Kevin Curran

As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.

Zoetis Could Be Seeing Its Correction Coming to an End

Bruce Kamich

The shares of the animal health company could be finding a bottom after losing substantial ground since the start of the year.

Dexcom's Charts Don't Make a Convincing Case for Its Shares

Bruce Kamich

The stock of the maker of glucose monitoring systems may be seeking a bottom but it isn't clear whether it has gotten there yet.

Walgreens Boots Alliance Is Ready to Break Out of Its Lengthy Consolidation

Bruce Kamich

Here's where traders could go long.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight